Company news
Aurora Cannabis Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Aurora Cannabis to Host First Quarter 2025 Investor Conference Call
July 29, 2024
Aurora Receives Expanded Cultivation and Unique Research Licenses for German Facility
July 25, 2024
Aurora Cannabis Inc. Announces Filing and Mailing of Management Information Circular in Connection with Upcoming Annual General and Special Meeting of Shareholders
July 9, 2024
Aurora Cannabis Files Full Year Results and Announces Fiscal 2024 Fourth Quarter
June 20, 2024
Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2024 Investor Conference Call and File Related Year End Information
June 7, 2024
Aurora Unveils Premium Resin Cartridges in Australia
June 5, 2024
Aurora Cannabis Announces Appointment of New Director
May 15, 2024
Aurora Marks First Shipment of Medical Cannabis to the New Zealand Market
May 8, 2024
Aurora Improves Offerings in Australia with New Range of Premium Dried Flower Products
April 30, 2024
Aurora Cannabis Commends Germany's Landmark Legalization Achievement
April 1, 2024
Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance
March 20, 2024
Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia
March 4, 2024
Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1]
February 29, 2024
Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis
February 28, 2024
Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation
February 20, 2024
Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million
February 8, 2024
Aurora Cannabis Acquires MedReleaf Australia
February 8, 2024
Aurora Cannabis Provides Business Update and Announces Date of Third Quarter Fiscal Year 2024 Investor Conference Call
January 31, 2024
Aurora Unveils Innovative Cannabis-Infused Ready-to-Drink Beverage in Latest Medical Product Launch
January 24, 2024
Aurora Cannabis Announces Fiscal 2024 Second Quarter Results and Delivers Record Positive Adjusted EBITDA
November 9, 2023
Aurora Cannabis to Host Second Quarter Fiscal Year 2024 Investor Conference Call
October 26, 2023
Aurora Cannabis Announces Settlement of Patent Litigation
October 24, 2023
Aurora Cannabis Inc. Announces Closing of its C$38.8 Million Bought Deal Financing, Including the Full Exercise of the Over-Allotment Option
October 3, 2023
Aurora Cannabis Inc. Announces C$34 Million Bought Deal Financing Intends to Repay Remaining Convertible Debt Balance
September 28, 2023
Aurora Launches Bold New Brand Tasty's into Canadian Adult Market
September 19, 2023
Aurora Confirms Approval of Transfer to Nasdaq Capital Market; Enters into Agreement to Repurchase a Further ~ US$9.6 Million Principal Amount of Convertible Notes
September 19, 2023
Aurora Repurchases ~US$9.0 Million Principal Amount of Convertible Notes; Continues Progress Towards Positive Free Cash Flow with less than ~US$39 Million of Notes Outstanding
September 8, 2023
Aurora Expands Strains for Heroes Offerings Designed for Veterans, by Veterans
September 7, 2023
Aurora Cannabis Partners with leading Brazilian company Herbarium to expand CBD Portfolio into Brazil
September 6, 2023
Aurora Cannabis Announces Results of 2023 Annual General Meeting
August 14, 2023
Aurora Cannabis Announces Fiscal 2024 First Quarter Results, and Delivers Record Positive Adjusted EBITDA
August 10, 2023
Aurora Launches Innovative Infused Pre-Rolls with 50%+ THC for Medical Cannabis Patients on AuroraMedical.com
August 1, 2023
Aurora Cannabis to Host First Quarter Fiscal Year 2024 Investor Conference Call
July 27, 2023
Aurora Cannabis Announces Sale of Aurora Sun Facility to Bevo Expected to Provide Incremental Revenue and Cash Flow
July 24, 2023
Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders
July 19, 2023
Aurora Cannabis Announces Fiscal 2023 Third Quarter and Files Full Year Results
June 14, 2023
Aurora Cannabis to Host Third Quarter and Fiscal Year 2023 Investor Conference Call and File Related Year End Information
June 7, 2023
Aurora Celebrates Summer with New Innovation Launching Across Canada
June 6, 2023
Aurora and Ethypharm Reaffirm their Commitment to Promote Access to Medical Cannabis for French Patients
May 30, 2023
Aurora Expands Medical Cannabis Portfolio in Germany: New flower varieties for patients with high THC needs
April 28, 2023
Aurora Cannabis Partners with Strainprint to Empower Patients on their Cannabis Journey
April 26, 2023
Aurora Introduces Fresh Innovation for Spring
April 25, 2023
Aurora Repurchases ~$22 Million Principal Amount of Convertible Notes, Saving $1.2 Million in Annualized Interest Payments and Leaving ~$79 Million (US$59) of Notes Outstanding; Balance Sheet Remains Among Strongest in Canadian Cannabis Industry
April 24, 2023
Aurora and MedReleaf Australia Launch IndiMed Tempo 26, Further Strengthening Product Offerings for Medical Cannabis Patients
April 12, 2023
Aurora Repurchases ~$47 Million Principal Amount of Convertible Notes, Saving $2.6 Million in Annualized Interest Payments; Balance Sheet Remains Among Strongest in Canadian Cannabis Industry
March 30, 2023
Aurora Provides Update on Nasdaq Listing
March 24, 2023
Aurora Cannabis Announces Filing of Preliminary Base Shelf Prospectus
March 17, 2023
Aurora Launches New Medical Flower Product, Valour - Designed for Veterans, by Veterans
March 2, 2023
Aurora and MedReleaf Australia Launch new Medical Cannabis Brand - CraftPlant
February 22, 2023
Aurora Cannabis Announces Fiscal 2023 Second Quarter Results
February 9, 2023
Calls
The 5 newest of 27 calls. Every call is listed under its year.
- Aurora Cannabis (TSX:ACB) Q1 2027 Earnings Call
Aug 5, 2026
Transcript - Aurora Cannabis (TSX:ACB) Q4 2026 Earnings Call
Jun 11, 2026
Transcript - Aurora Cannabis (TSX:ACB) Q3 2026 Earnings Call
Feb 4, 2026
Transcript - Aurora Cannabis (TSX:ACB) Q2 2026 Earnings Call
Nov 5, 2025
Transcript - Aurora Cannabis (TSX:ACB) Q1 2026 Earnings Call
Aug 6, 2025
Transcript
Decks
The 5 newest of 18 decks. Every deck is listed under its year.
- Q3 2026 Earnings Presentation
Earnings · 15 slides · Feb 4, 2026
- Q2 2026 Earnings Presentation
Earnings · 15 slides · Nov 5, 2025
- Q1 2026 Earnings Presentation
Earnings · 20 slides · Aug 6, 2025
- Q4 2025 Earnings Presentation
Earnings · 18 slides · Jun 18, 2025
- Q3 2025 Earnings Presentation
Earnings · 19 slides · Feb 5, 2025